A critical breakthrough in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant suppressor protein is frequently disabled in several types of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research